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Case Report
Death due to Acute Massive Pulmonary
Thromboembolism Associated with Risperidone
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Abstract
The antipsychotic drug risperidone, which is extensively used, has also many side effects, as increased risk of
stroke, thrombosis, and pulmonary embolism have been reported. We present a case of a 38 year-old-woman
with psychiatric disorder who got worse in her home and died in the hospital. Throughout autopsy, during the
internal examination, multiple thrombi in the pulmonary artery branches were observed; however, there were no
pathology findings in the lower extremity veins. Blood chemistry test revealed 4 ng/ml of risperidone, 37 ng/ml
of quetiapine and atropine; chemical examination of urine detected atropine, quetiapine, risperidone. Death
occurred due to acute massive pulmonary thromboembolism. We aimed to discuss this case with autopsy and
histopathologic findings, laboratory results in medico-legal literature.
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Problem statement and analysis of
the latest research
Risperidone is an extensively used antipsychotic
drug; however, due to hyperactivation of blood
platelets, there have been reported many side ef-
fects including increased risk of stroke, thrombosis,
pulmonary embolism [1]. Pulmonary thromboem-
bolism is a true medical emergency; pulmonary
hypertension progresses rapidly thereby leading to
right-sided heart failure which may be the cause
of death [2]. Some antipsychotic agents have been
reported as a risk factor for thromboembolism in
adult patients with psychiatric disorders [3].
The objective of the research was to discuss
this case with autopsy and histopathologic findings,
laboratory results in comparison with medicolegal
literature.
1. Case Report
We present a case of a 38 year-old-woman with psy-
chiatric disorder who got worse in her home and
died after admission to the public hospital. Autopsy
was mandated by local prosecutor afer final inves-
tigation. Throughout autopsy, during the external
examination, ecchymosis due to the catheter on the
bilateral medial part of the wrists and bilateral dor-
sum of the hands, and the areas of skin burn on the
chest due to extensive defibrillation were detected.
During the internal examination, petechial haem-
orrhages on the surface of the lungs, pulmonary
congestion and edema, massive thromboembolism,
multiple thrombi in pulmonary artery branches were
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Figure 1. Massive thromboembolism.
Figure 2. Multiple thrombi in the pulmonary
artery branches.
observed (Fig. 1, 2) and there were no pathology
findings in the lower extremity veins. In the larynx
and trachea, there were mucoid secretions.
Histopathological examination in sections of the
lungs revealed edemas, congestion and thrombi in
the lumen of the large and small branches of the
pulmonary artery vessels adhering to the wall of
the intima vessels. Blood chemistry test revealed
4 ng/ml of risperidone, 37 ng/ml of quetiapine and
atropine; chemical examination of urine detected
atropine, quetiapine, risperidone. Death was re-
ported to occur due to acute massive pulmonary
thromboembolism.
2. Discussion
Risperidone is an atypical antipsychotic drug that
belongs to the chemical class of benzisoxazole deriva-
tives and is used to treat a number of psychiatric
diseases, such as schizophrenia, schizoaffective dis-
order, mixed-manic states associated with bipolar
disorder and irritability in children with autism [4].
The side effects in the patients receiving risperi-
done are numerous and sometimes fatal [4]. Al-
though the causes of death associated with the use
of risperidone were different, most of them ap-
peared to be related either to infections or cardiovas-
cular events [4]. Venous thromboembolism (VTE)
is a relatively common cardiovascular disease and
pulmonary embolism ranks second among causes
of out-of-hospital sudden death [4, 5]. Among a
number of inherited and acquired risk factors, an-
tipsychotic therapy is a well-known iatrogenic risk
factor for VTE [4]. Although conventional agents
have been associated with enhanced aggregation
of platelets, atypical antipsychotic agents have not
been tested systematically [3, 6]. Recent in vitro
data from the manufacturer of risperidone do not
confirm a direct effect of risperidone on human
platelet function, plasma coagulation, and fibrinol-
ysis [3, 7]. However, atypical agents possess a
high affinity for the serotonin receptor type 2A,
and serotonin-induced platelet aggregation may be
affected [3, 8]. Evidence also exists that lupus anti-
coagulant and anticardiolipin antibody levels may
be raised in the patients taking conventional antipsy-
chotic agents [3, 9]. Venous stasis can be exacer-
bated by excessive sedation [3, 10]. This presen-
tation will impact the forensic science community
by providing an understanding of the importance
of atypical antipsychotic agents which appear to
increase the risk of thromboembolism
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